Join
Live feed
·
NEWSReleasevia Quantisnow
Eli Lilly and Company logo
Novo Nordisk A/S logo

Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications

ByQuantisnow·Wall Street's wire, on your screen.
LLY· Eli Lilly and CompanyNVO· Novo Nordisk A/S
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LLY (Eli Lilly and Company), NVO (Novo Nordisk A/S) and more on Quantisnow.